Statement
24 Mar 2026
WTO 14th Ministerial Conference: An opportunity to address trade, innovation, and health
As WTO Members gather in Yaoundé for the 14th Ministerial Conference (MC14), the meeting comes at a pivotal moment for global trade and health.
Read more
Position paper
4 Mar 2026
Artificial intelligence in pharmaceutical manufacturing – navigating innovation and regulation
Artificial Intelligence (AI) and Machine Learning (ML) are rapidly transforming various sectors, and the pharmaceutical manufacturing industry is no exception. This paper explores how the pharmaceutical industry may use individual applications of AI in pharmaceutical manufacturing and control. It describes the evolving regulatory landscape and provides key considerations for national regulatory authorities (NRA) when reviewing...
Read more
Statement
4 Feb 2026
158th session of the WHO Executive Board: Substandard and falsified medical products
On 4 February 2026, IAPO delivered a statement on Agenda item 12 on substandard and falsified medical products at the 158th session of the WHO Executive Board on behalf of the Fight the Fakes Alliance, of which IFPMA is a member. The International Alliance of Patients’ Organizations, on behalf of the Fight the Fakes Alliance,...
Read more